June 25, 2019 | City of Hope
City of Hope has accelerated its plans for a $1 billion comprehensive cancer campus in Orange County, bringing highly specialized cancer care, clinical trials, precision medicine and early detection to the nation’s sixth most populous county.
City of Hope’s expansion to Orange County is personal for this cancer survivor
February 4, 2019 | City of Hope
Bringing City of Hope cancer services closer to Orange County residents is work that is personal to Frank DiBella, a 73-year-old Newport Beach, California, resident and bladder cancer survivor.
A mind-body approach to treating kidney cancer patients
August 13, 2018 | Zen Vuong
Patients with metastatic kidney cancer who have high rates of distress tend to have poorer overall survival compared to those with low distress, according to a new study by City of Hope researchers.
City of Hope Researchers Publish First Report on a Protein Inhibitor for Advanced Bladder Cancer
June 8, 2018 | Letisia Marquez
Advanced bladder cancer is particularly difficult to treat. The five-year survival rate for Stage 4 bladder cancer is only about 15 percent. Now, City of Hope researchers have discovered a that a novel drug blocks a key protein that drives the disease.
New Target for Prostate Cancer Treatment and Prevention Identified
March 29, 2017 | Katie Neith
While prostate cancer is often treated successfully, it is still the third leading cancer killer among men and represents a huge health and economic burden. Now, a team from City of Hope believes they have found a key mechanism for potentially keeping the disease at bay, both before and after diagnosis.
Liquid Biopsy Offers a New Way to Target Kidney Cancer
February 17, 2017 | Denise Heady
Despite a wave of new targeted therapies being approved to treat kidney cancer, many of those therapies have been challenging to use because of the difficulty in obtaining cancer tissue for genomic testing. Now, researchers may have found a way to combat this problem: the liquid biopsy.
2017 Rose Parade: 8 questions for kidney cancer patient Dave Pasternak
December 6, 2016 | Denise Heady
For the 45th year in a row, City of Hope will participate in the Tournament of Roses Parade. This year, seven patients will welcome 2017 atop City of Hope’s Rose Parade float. Meet kidney cancer patient Dave Pasternak.
Cancer Insights: Molecular profiling unlocks tumor answers
October 27, 2016 | Sumanta K. Pal, M.D.
Molecular profiling, unlike any other type of controversial profiling in the news, is an extremely hot topic in cancer medicine today, and it’s going to have a huge impact on patients, physicians and payers.